Children who could develop attention-deficit hyperactivity disorder (ADHD) are more likely to have mothers who are gentically programmed to have a defective production of serotonin.

Anne Halmøy, M.D., of University of Bergen, Norway, and colleagues studied 459 adult outpatients with ADHD, 97 of their family members and 187 control individuals recruited from across Norway. Participants provided blood samples for gene sequencing along with information about psychiatric diagnoses and symptoms.
By sequencing 646 individuals, the researchers identified nine different mutations, of which eight were significantly associated with impaired function of the enzymes. Family analysis of 38 individuals who carried these mutations and 41 of their offspring revealed that children of mothers who had one of the mutations-and, therefore, had impaired serotonin production-had a 1.5- to 2.5-time higher risk of ADHD than control individuals or offspring of fathers with the mutations.
There was a large variance in the number and severity of symptoms reported by these individuals, suggesting that for offspring of mothers with these mutations, "the clinical outcome probably depends on a sum of many different genetic or environmental factors in addition to variations in maternal serotonin levels."
The results may have public health implications, the authors note. "Whether it is caused by genetic vulnerability, chronic inflammation, malnutrition or other processes, maternal serotonin deficiency during pregnancy might predispose to neuropsychiatric disorders and cardiovascular illnesses," they conclude. "However, further replication studies, preferably in larger samples, will be required to corroborate this relationship."
MEDINDIA



Email










